Jonathan Bardahl

BMT and cellular therapy fellow. Future BMT doctor. Tweets are my own. Not medical advice.

[Kris Mahadeo @MahadeoKris]

Agenda for our Fall 23 PALISI HCT CI Meeting. #palisi 2PM celebration of #duke_childrens Dr Paul L Martin.

[Jonathan Bardahl @JonDOmore]

500 patients treated with CART in 11 years! Rock on #immunotherapy

[Cancer Center @ CHOP @CHOPCancerCntr]

In a major milestone for pediatric cancer treatment, our Center has treated its 500th patient with CAR T-cell immunotherapy. Learn more at: https://t.co/qW3MRZNFjg.

[Jonathan Bardahl @JonDOmore]

Looking forward to attending virtually!

[Cancer Center @ CHOP @CHOPCancerCntr]

It's not too late to register for #CelliconValley '23! Held on June 21-23, the event will bring together world experts to share the latest findings and discuss best practices, novel strategies and future developments in field of #cellandgenetherapy. More: https://t.co/cSoUezw5dB.

[Jonathan Bardahl @JonDOmore]

I will be attending virtual and looking forward to all the presentations! https://t.co/FRdrde6tVL

[Jonathan Bardahl @JonDOmore]

Promising results!

[AAACTT @AAACTT_org]

PTCy, Abatacept and Short Course Tacrolimus, a feasible combination for acute GVHD prevention following haploidentical PB transplantations.
‘CAST regimen’

https://t.co/SNlQBqrfdD

[Jonathan Bardahl @JonDOmore]

Interesting single institution experience! AML therapy is INTENSE, and if we can find comparable regimens that would be great. These pts would also have less toxicities if needing transplant in the future @ASTCT @CIBMTR

[Hemalatha Rangarajan MD https @hmgcoa2]

FLAG-IDA font line therapy in AML in peda, reduced anthracyclinw exposure in peds.. comprable outcomes https://t.co/fvN0bN90NQ

[Jonathan Bardahl @JonDOmore]

Lower rates of #Gvhd but higher rates of viral reactivation. Got to pick your battles! @ASTCT @CIBMTR

[Transplantation and Cellular Therapy Journal @ASTCT_Journal]

New study finds that PTCy may correlate with lower rates of acute/chronic #GVHD and better survival outcomes. Read more about the study: https://t.co/HdiEz5ZYTB @ELShematology

[Transplantation and Cellular Therapy Journal @ASTCT_Journal]

New study finds that PTCy may correlate with lower rates of acute/chronic #GVHD and better survival outcomes. Read more about the study: https://t.co/HdiEz5ZYTB @ELShematology

[Alexandra Gomez A. @AGomez_MD]

Excellent in-depth talk on HHV6 after #bmtsm by @JoshuaHillMD #MSKTOXTCT Some learning #️⃣1️⃣HHV6 Viremia is common 2️⃣ hhv6 encephalitis is rare (1-10%, 5-10%in CBU) 2️⃣Presentation for encephalitis can be subtle (SIADH➡️thinks HHV6) 3️⃣association with subsequent aGVHD 4️⃣PTCy↗️risk

[Jonathan Bardahl @JonDOmore]

Metabolic disorders can also benefit from stem cell transplant! Importance is screening to catch early so lethal metabolic byproducts don’t build up before transplant. @ASTCT @CIBMTR

[Kris Mahadeo @MahadeoKris]

Master class in Hurler Syndrome. Dr Prasad discussing impact of newborn screening and Duke’s outcomes. @Duke_Childrens #EBMT23

[Jonathan Bardahl @JonDOmore]

Patients with sickle cell disease can be offered a cure with transplant. One major obstacle is availability of donors.

[Susan Prockop MD @SusanProckopMD]

Mohamed Bayoumy #EBMT2023 sharing experience in sickle cell disease - safety of donors with trait.

[Jonathan Bardahl @JonDOmore]

Finding ways to improve transplant success and limit side effects is what it’s all about! #pedshemonc

[GvHD Hub @gvhd_hub]

CONGRESS #EBMT23 | Leo Luznik @HopkinsMedicine presents the keynote lecture on PTCy during the opening ceremony of EBMT23. He talks through the the history of the use of PTCy then addresses the current unknowns and future frontiers #bmtsm #GvHD

[Jonathan Bardahl @JonDOmore]

Peds #Tandem23 track, talking immune mechanisms for relapse @ASTCT @CIBMTR

[National Board of Osteopathic Medical Examiners @NBOME]

More than 4000 DO students sit for both COMLEX and USMLE, paying over $5 million out of pocket. But they don’t have to. Learn how the NBOME, along with the UGRC, is aiming to reduce the perceived need to be tested twice: https://t.co/2rzWKRmWn6

[National Board of Osteopathic Medical Examiners @NBOME]

Just updated – new information on COMLEX-USA Level 1 scoring is now available here: https://t.co/59k7TQceB7

[National Board of Osteopathic Medical Examiners @NBOME]

Challenged by @JulieSeesDO to post four pictures from the pandemic. We challenge @AOAforDOs @COSGP @NationalSOMA @AACOMmunities @eleyeiser @rmistry91 @champlippmann @JonDOmore

[National Board of Osteopathic Medical Examiners @NBOME]

Courtney Cox @therealcourtcox, OMS-IV at @MidwesternUniv is an incoming PGY-1 at @DoctorsEMres and matched into EM with only #COMLEX-USA scores. Hear her story in our latest #StoriesfromtheRoad

https://t.co/m6ynqElM3G

#RTDOL #RoadtoDOLicensure #EMSWeek

[AOA @AOAforDOs]

Last week, we celebrated #NOMWeek by exploring the theme We Are Osteopathic Medicine through stories shared by DOs and students. Your submissions inspired us, just as your work does every day. Thank you. @rburns_DO

[National Board of Osteopathic Medical Examiners @NBOME]

NBOME update on #COVID19: a letter from our President & CEO, @JohnGimp.
Read it here: https://t.co/t5cgHIYNE5
@AACOMmunities @AOAforDOs

[National Board of Osteopathic Medical Examiners @NBOME]

NBOME is sensitive to the confusion surrounding #COMLEX-USA rescheduling at Prometric Test Centers. We are working closely with them to better understand the situation and provide greater clarity to our candidates. More here: https://t.co/xeWDTX63vh